Overall survival in patients with SCID who received non-MSD HCT
| Outcome | NH White, N = 421 | Hispanic, N = 174 | Black, N = 77 | Asian/PI, N = 37 | Native American, N = 33 | Unknown/Other, N = 54 | P value |
|---|---|---|---|---|---|---|---|
| OS | <0.01 | ||||||
| Unadjusted HR for OS (95%CI) | ref | 1.34 (0.94, 1.90) | 2.43 (1.62, 3.65) | 1.79 (0.98, 3.26) | 0.74 (0.35, 1.59) | 2.00 (1.22, 3.28) | |
| 1-year OS | 84.6 (80.8–87.8) | 78.6 (71.7–84.0) | 72.6 (61.2–81.2) | 78.4 (61.4–88.6) | 84.4 (66.5–93.2) | 69.9 (55.6–80.3) | |
| 5-year OS | 78.8 (74.4–82.5) | 71.9 (64.4–78.2) | 60.0 (47.9–70.1) | 64.4 (46.5–77.6) | 81.3 (63.0–91.1) | 67.8 (53.3–78.6) | |
| Outcome | NH White, | Hispanic, | Black, | Asian/PI, | Native American, | Unknown/Other, | P value |
|---|---|---|---|---|---|---|---|
| OS | <0.01 | ||||||
| Unadjusted HR for OS (95%CI) | ref | 1.34 (0.94, 1.90) | 2.43 (1.62, 3.65) | 1.79 (0.98, 3.26) | 0.74 (0.35, 1.59) | 2.00 (1.22, 3.28) | |
| 1-year OS | 84.6 (80.8–87.8) | 78.6 (71.7–84.0) | 72.6 (61.2–81.2) | 78.4 (61.4–88.6) | 84.4 (66.5–93.2) | 69.9 (55.6–80.3) | |
| 5-year OS | 78.8 (74.4–82.5) | 71.9 (64.4–78.2) | 60.0 (47.9–70.1) | 64.4 (46.5–77.6) | 81.3 (63.0–91.1) | 67.8 (53.3–78.6) | |
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.